NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

But yet Dr. Liau has filed a patent for the UCLA ATL that is different than the patent UCLA has licensed to NWBO.

UCLA ATL Dendritic Vaccine Patent
Patent case reference: UCLA Case No. 2015-341 (pending).? This patent covers the autologous tumor lysate-pulsed dendritic cell vaccination platform developed for high-grade gliomas and is associated with UCLA researchers.

NWBO Licensed Dendritic Vaccine Patents US Patent Numbers:
US8389278B2 – Manufacturing process for enhanced dendritic cells.?
US9744193B2 – “Dendritic Cell Vaccines and Uses Thereof” (identified as a foundational patent for DCVax-L).